Big news in global efforts to #EndTB . Johnson & Johnson has granted a voluntary license to Stop TB Partnership’s Global Drug Facility to procure & supply generic versions of lifesaving #TB drug bedaquiline for the majority of low and middle income countries with high burdens of TB. @jnjnews

5 months. 3 cities. Countless experiences. Happy #CanadaDay !

Day 1 of joining Madhu Pai, MD, PhD and his brilliant team of TB researchers and advocates! #thrilled #gratitude #NewBeginnings #PaiTeam